Supreme Court rejects Covidien bid to restore patent verdict against Ethicon
In refusing to hear the case, the high court left in place a December 2014 ruling by the U.S. Court of Appeals for the Federal Circuit that threw out a judge’s finding that Ethicon had infringed upon Covidien’s patents for surgical cutting tools. Covidien is owned by Medtronic Plc.
In a separate patent case, the court declined to hear Biolitec AG’s challenge to a $70 million contempt finding relating to a patent dispute the company had with AngioDynamics Inc.
The court’s refusal to take the case means a March ruling by the 1st U.S. Circuit Court of Appeals in favor of AngioDynamics remains intact.
Source: Reuters Health